Drug Search by Year (Detail)

26474338

US

Skin necrosis, Bacteraemia, Neutrophilic dermatosis, Pathogen resistance, Fungal skin infection, Infection, Fusarium infection,

TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN,

26474797

EU

Follicular lymphoma, Death, Cardiac failure, Breast cancer, Diffuse large B-cell lymphoma, Febrile neutropenia, Atrial fibrillation, Pulmonary embolism, Neutropenia, Therapeutic product effect incomplete, Infection, Toxicity to various agents, Renal cancer, Transitional cell carcinoma, Adenocarcinoma of colon, Intraductal papillary mucinous neoplasm, Gastrointestinal neuroendocrine tumour, Kaposi^s sarcoma, Lung adenocarcinoma, Central nervous system lymphoma,

FILGRASTIM, ACYCLOVIR, BENDAMUSTINE HCL,

26470995

Psoriasis, Folliculitis, Infection, Blepharitis, Nasal ulcer, Gingival bleeding,

CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL,

26471067

Infection, Off label use,

BIMEKIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, DAPAGLIFLOZIN, ALLOPURINOL, AMLODIPINE,

26469978

CA

Pneumonia, Asthma, Infection,

BENRALIZUMAB, BENRALIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, UMECLIDINIUM,

26470111

US

Drug hypersensitivity, Ulcer, Infection,

26470378

EU

Infection, Aneurysm, Sensory loss, Oedema peripheral,

PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOSPORINE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MEROPENEM,

26473400

Pyrexia, Infection, Disease complication,

TAFAMIDIS,

26465217

US

Plasma cell myeloma, Back pain, Inflammation, Musculoskeletal disorder, Arthralgia, Adverse drug reaction, Gait disturbance, Hypersensitivity, Infection, Metastasis, Computerised tomogram abnormal, Immunosuppression,

RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, THYROID, PORCINE,

26465878

EU

Asthenia, Gastrointestinal pain, Fatigue, Infection, Influenza, Therapy partial responder,

ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, HYDROCORTISONE,

26465968

EU

Hypogammaglobulinaemia, Off label use, Infection,

RITUXIMAB, TOCILIZUMAB,

26466233

US

Colitis ulcerative, Vomiting, Weight fluctuation, Impaired quality of life, Infection, Arthralgia, Diarrhoea, Abdominal pain, Fatigue, Nausea,

VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PROPRANOLOL HYDROCHLORIDE, QUETIAPINE, QUETIAPINE, QUETIAPINE, QUETIAPINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, PREDNISONE, HYDROXYZINE PAMOATE, METHYLPREDNISOLONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CYANOCOBALAMIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE,

26466290

EU

Multiple organ dysfunction syndrome, Hepatocellular injury, Cardiac failure, Neuropathy peripheral, Infection, Nephropathy, Eosinophilic granulomatosis with polyangiitis, Therapy partial responder,

MACITENTAN, TREPROSTINIL, RIOCIGUAT, RIOCIGUAT, FUROSEMIDE, SELEXIPAG, SELEXIPAG,

26466371

US

Infection,

VELAGLUCERASE ALFA,

26466857

CN

Cytomegalovirus infection reactivation, Epstein-Barr virus infection reactivation, Infection,

RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, BUSULFAN,

26467274

EU

Haemolysis, Infection, Haemoglobin decreased,

RAVULIZUMAB,

26467546

US

Fall, Infection,

AVAPRITINIB,

26467653

Infection, Off label use,

CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IRON, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL,

26467760

US

Urticaria, Stress, Joint injury, Infection,

OMALIZUMAB,

26467828

CA

White blood cell count increased, Infection, Dyspnoea, Dizziness, Blood pressure decreased, Diarrhoea, Hypovolaemia, Fatigue, Hypersomnia, Vomiting,

TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL,

26468248

PA

Death, Neutropenia, Infection, Toxicity to various agents,

DARATUMUMAB, TECLISTAMAB-CQYV,

26468671

CN

White blood cells urine positive, Temperature intolerance, Pyrexia, Infection,

MYCOPHENOLIC ACID, MYCOPHENOLIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, SIROLIMUS,

26468707

US

Pneumonia, Peripheral swelling, Muscle spasms, Product administration interrupted, Hereditary angioedema, Malaise, Liquid product physical issue, Constipation, Decreased appetite, Fungal infection, Illness, Sinusitis, Drug hypersensitivity, Urine output decreased, Infection,

LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ICATIBANT ACETATE, OMALIZUMAB,

26468742

CN

Infection, Pneumonia, Myelosuppression, Asthenia, Decreased appetite, Nausea, Vomiting, Retching, Abdominal distension,

CYTARABINE,

26468743

JP

Infection, Pyrexia, C-reactive protein increased,

FOLIC ACID, ABATACEPT,

26468780

GB

Gastrointestinal haemorrhage, Hepatic fibrosis, Multiple organ dysfunction syndrome, Septic shock, Oesophageal varices haemorrhage, Varices oesophageal, Portal hypertension, Infection, Myocardial ischaemia,

METHOTREXATE SODIUM,

26469000

MX

Infection,

PALIVIZUMAB, PALIVIZUMAB,

26469015

US

Infection,

FRUQUINTINIB,

26469102

US

Infection,

26469534

US

Infection,

DIROXIMEL FUMARATE,

26469706

EU

Death, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Infection,

AXICABTAGENE CILOLEUCEL,

26469839

Illness, Infection, Hidradenitis,

BIMEKIZUMAB,

26460571

CA

Infection, Weight decreased, Pain, Decreased appetite, Swelling,

26460604

EU

Death, Renal impairment, Renal failure, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Hepatic function abnormal, Cytomegalovirus test positive, Infection,

BREXUCABTAGENE AUTOLEUCEL,

26461042

US

Infection,

NEMOLIZUMAB-ILTO,

26461099

Gastrointestinal haemorrhage, Infection, Arthralgia, Hypoaesthesia, Herpes zoster, Joint swelling, Psoriasis, Sticky skin, Raynaud^s phenomenon, Mass, Proctocolectomy, Colostomy bag user, Device malfunction, Drug dose omission by device, Device dispensing error, Drug ineffective, Inappropriate schedule of product administration,

BIMEKIZUMAB, BIMEKIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, NAPROXEN, NAPROXEN SODIUM,

26461214

CA

Bacterial infection, Forced expiratory volume decreased, Influenza, Musculoskeletal chest pain, Fungal infection, Obstructive airways disorder, Pneumonia, Tachycardia, Urticaria, Vomiting, Blood pressure increased, Decreased activity, Nasal congestion, Pain, Productive cough, Rales, Upper-airway cough syndrome, Vertigo, Dizziness, Psoriasis, Rhinitis, Terminal insomnia, Therapeutic product effect decreased, Therapeutic response decreased, Cough, Diarrhoea, Emphysema, Malaise, Nasal discharge discolouration, Urinary tract infection, Wheezing, Abdominal pain, Asthma, Dyspnoea exertional, Eczema, Feeding disorder, Full blood count abnormal, Oropharyngeal pain, Sleep disorder, Sleep disorder due to a general medical condition, Ear infection, Middle insomnia, Migraine, Nasopharyngitis, Restrictive pulmonary disease, Sinusitis, Stress, Anxiety, Drug ineffective, Dyspnoea, Eosinophil count abnormal, Heart rate increased, Infection, Product administration error, Tooth abscess,

QUETIAPINE FUMARATE, QUETIAPINE, MONTELUKAST SODIUM, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, CICLESONIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE,

26461688

CN

Thrombocytopenia, Neutropenia, Sepsis, Febrile neutropenia, Respiratory tract infection, Oral infection, Soft tissue infection, Infection, Pyrexia,

DARATUMUMAB, LENALIDOMIDE, ETOPOSIDE, CYTARABINE,

26461713

US

Aspiration, Infection,

ETEPLIRSEN,

26461774

CN

Myelosuppression, Infection,

DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS,

26461964

US

Infection,

MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES,

26462334

CA

Malaise, Diverticulitis, Pyrexia, Infection, Heart rate increased, Emotional distress, Anxiety, Stress, Feeling hot, Illness,

ETANERCEPT, ETANERCEPT, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, TELMISARTAN, LORAZEPAM,

26462360

US

Device leakage, Product dose omission issue, Illness, Nasopharyngitis, Adverse drug reaction, Abdominal discomfort, Infection,

GUSELKUMAB, GUSELKUMAB,

26462397

Infection,

BIMEKIZUMAB,

26462816

Urinary tract infection, Infection, Hospitalisation, Septic shock, Injection site pain, Oral candidiasis, Hidradenitis, Condition aggravated, Product dose omission issue,

BIMEKIZUMAB, BIMEKIZUMAB,

26462981

GB

Atrial fibrillation, Electrocardiogram QT prolonged, Mental impairment, Hallucination, Delusion, Decreased appetite, Poor quality sleep, Haemoglobin decreased, Eosinophil count decreased, Infection, Neutrophil count decreased, Restlessness, Anxiety, Agitation, Therapeutic product effect incomplete, Treatment noncompliance, Off label use,

PREGABALIN, PREGABALIN, CLOZAPINE, CLOZAPINE, AMISULPRIDE,

26463167

EU

Infection, Vaccination failure,

26463252

EU

Abortion spontaneous, Congenital anomaly, Infection, Adverse event, Exposure during pregnancy,

INFLIXIMAB, USTEKINUMAB, GOLIMUMAB,

26463379

US

Leg amputation, Infection,

26463601

Renal cancer, Thrombosis, Infection,

DOLUTEGRAVIR SODIUM, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, PREDNISONE, HYDRALAZINE HYDROCHLORIDE,

26463869

Renal cancer, Thrombosis, Infection,

DOLUTEGRAVIR SODIUM, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, PREDNISONE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, HYDRALAZINE HYDROCHLORIDE,

26463963

EU

Right ventricular failure, Pulmonary hypertension, Antisynthetase syndrome, Respiratory tract infection, Cytokine release syndrome, Infection, Drug effective for unapproved indication, Off label use,

BLINATUMOMAB, BLINATUMOMAB,

26464057

CN

Asthma, Infection, Inappropriate schedule of product administration,

MEPOLIZUMAB,

26464180

BR

Infection, Systemic lupus erythematosus, Nephritis, Drug effective for unapproved indication, Depression, Anxiety, Stress, Off label use,

RITUXIMAB,

26464213

US

Dysarthria, Infection, Herpes zoster, Heart rate increased, Dyspnoea, Fatigue,

26464337

AR

Infection,

BRIGATINIB,

26464441

CN

Myelosuppression, Infection, Rash erythematous,

CYTARABINE, METHOTREXATE SODIUM, METHOTREXATE SODIUM,

26464454

CN

Infection, Pyrexia, Temperature intolerance, White blood cells urine positive,

MYCOPHENOLIC ACID, MYCOPHENOLIC ACID, METHYLPREDNISOLONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, SIROLIMUS,

26464455

CA

Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Sinusitis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Contraindicated product administered,

ETANERCEPT, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, TOFACITINIB, PREDNISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOSAPREPITANT DIMEGLUMINE, INFLIXIMAB, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, FOLIC ACID, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, ABATACEPT, OXYCODONE, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION,

26464481

US

Infection,

CILTACABTAGENE AUTOLEUCEL,

26464568

EU

Tumour lysis syndrome, Infusion related reaction, Infection,

RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, CYTARABINE, OXALIPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

26464740

CA

Ear operation, Infection, Pain,

ZOLEDRONIC ACID,

26464880

CA

Surgery, Infection,

RISANKIZUMAB-RZAA,

26464942

CA

Product dose omission issue, Product use issue, Infection, Neuropathy peripheral, Pneumonia,

BORTEZOMIB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB,

26465087

EU

Migraine, Oropharyngeal pain, Hypersensitivity, Infection, Therapeutic product effect decreased, Therapeutic response unexpected,

INFLIXIMAB, INFLIXIMAB, ERENUMAB-AOOE, ERENUMAB-AOOE,

26467611

Infection, Gastrooesophageal reflux disease,

PIRFENIDONE,

26467853

Dermatitis atopic, Infection, Skin papilloma,

CYCLOSPORINE,

26456969

JP

Angiopathy, Infection, Neoplasm, Cerebrovascular accident, Graft loss, Cardiovascular disorder, Viral infection,

RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, BASILIXIMAB,

26457094

US

Infection, Irritability, Paranoia, Therapy interrupted,

PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE,

26457389

EU

Tuberculosis of central nervous system, Mycobacterium abscessus infection, Mycobacterial infection, Osteolysis, Seizure, Fistula, Infection, Paradoxical drug reaction, Wound dehiscence, Gait disturbance, Pyrexia,

MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ISONIAZID, PREDNISONE, PYRAZINAMIDE, RIFAMPIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE,

26457550

US

Infection,

VENETOCLAX, PREGABALIN, SPIRONOLACTONE, COLCHICINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ALLOPURINOL, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, ACYCLOVIR, LOSARTAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, BUMETANIDE, CARVEDILOL, LINACLOTIDE,

26457679

CN

Myelosuppression, Neutropenia, Infection, Ecchymosis, Petechiae, Dental caries, Skin haemorrhage, White blood cell count decreased, Red blood cell count decreased, Platelet count decreased, Pyrexia, Mouth haemorrhage,

VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR,

26457791

EU

Infection, Injection site abscess,

INTERFERON BETA-1A,

26458096

EU

Infection, Pulmonary toxicity, Cardiovascular disorder, Renal disorder, Neoplasm,

RITUXIMAB,

26458194

EU

Arrhythmia, Infection,

OBINUTUZUMAB, VENETOCLAX, CHLORAMBUCIL,

26458352

CA

Influenza, Malaise, Infection,

BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, TIOTROPIUM BROMIDE INHALATION SPRAY,

26458481

CA

Infection, Maternal exposure during pregnancy,

26458502

US

Cardiac disorder, Infection,

LENALIDOMIDE,

26458848

CN

Myelosuppression, Nausea, Vomiting, Full blood count decreased, Infection, Neutrophil count decreased, Pyrexia,

VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR,

26458906

Infection,

BIMEKIZUMAB,

26459191

CA

Infection, Hypotension, Asthenia, Confusional state, Pyrexia, Lipase increased,

ELAFIBRANOR, USODIOL, AMLODIPINE, MIRTAZAPINE, ERGOCALCIFEROL, BISOPROLOL FUMARATE, EZETIMIBE, AMLODIPINE, CHOLESTYRAMINE, LACTULOSE,

26459266

EU

Graft versus host disease, Mucosal inflammation, Pyrexia, Infection,

RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE, MELPHALAN, THIOTEPA, FLUDARABINE PHOSPHATE,

26459324

US

Infection,

ELRANATAMAB-BCMM,

26459464

US

Infection,

TECLISTAMAB-CQYV,

26459543

Infection, Hospitalisation, Product prescribing issue, Therapy interrupted,

CERTOLIZUMAB PEGOL,

26459644

ZA

Purulent discharge, Infection, Application site scar, Application site scab, Application site burn, Pain,

26459794

CA

Infection, Gait disturbance, Syncope, Seizure, Lymphocyte count decreased,

CLADRIBINE, CLADRIBINE,

26460067

CN

Myelosuppression, Dizziness, Asthenia, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Pyrexia, Temperature intolerance, Infection,

CYTARABINE, CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE,

26460126

CA

Infarction, Infection, Product intolerance,

ICOSAPENT ETHYL,

26460199

GB

Neutropenic sepsis, Electrocardiogram QT prolonged, Sinus bradycardia, Infection,

CYTARABINE, QUIZARTINIB, QUIZARTINIB, QUIZARTINIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, APIXABAN,

26460304

US

Immune effector cell-associated neurotoxicity syndrome, Cytokine release syndrome, Neutropenia, Thrombocytopenia, Infection, Anaemia, Parkinsonism,

CILTACABTAGENE AUTOLEUCEL,

26460477

US

Infection,

LENALIDOMIDE,

26462879

Chemical burn, Fungal infection, Infection,

MICONAZOLE NITRATE,

26462893

Therapy interrupted, Infection, Sinusitis, Headache, Depression,

ADALIMUMAB,

26453029

US

Infection, Product dose omission issue,

TROFINETIDE,

26453185

JP

Infection, Immune-mediated thyroiditis, Pyrexia,

PEMBROLIZUMAB,

26453958

US

Colitis ulcerative, Rectal ulcer, Infection, Impaired quality of life, Alopecia, Arthralgia,

VEDOLIZUMAB, VEDOLIZUMAB,

26454152

CA

Adjustment disorder with depressed mood, Amnesia, Anxiety, Asthenia, Asthma, Autoimmune disorder, Breast cancer stage II, Bursitis, C-reactive protein abnormal, Chest pain, Confusional state, Contusion, Deep vein thrombosis postoperative, Delirium, Depression, Dry mouth, Ear pain, Folliculitis, Gait inability, Grip strength decreased, Incorrect route of product administration, Infection, Memory impairment, Off label use, Wound infection,

TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB,

26454172

MX

Death, T-cell lymphoma, Infection, Necrosis, Pathogen resistance, Pseudomonas aeruginosa meningitis,

DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,

26454285

Infection, Device leakage,

CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL,